JPRN-jRCT2080223225未知1 期
A Study to Evaluate the Safety and Tolerability of Subcutaneous Treprostinil and Pharmacokinetics of a Novel LY900014 Formulation in Healthy Japanese Subjects (I8B-JE-ITRK)
适应症
试验速览
- 阶段
- 1 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Inclusion Criteria:
- •Overtly healthy Japanese
- •Body mass index (BMI) 18.5 - 25 kilograms per square meter (kg/m2)
- •Fasting plasma glucose >=71 milligrams per deciliter (mg/dL) (3.9 millimoles per liter [mmol/L]) and <108 mg/dL (6.0 mmol/L) (Part B only)
- •Have normal blood pressure, pulse rate, electrocardiogram (ECG), blood and urine laboratory test results that are acceptable for the study
排除标准
- •Are currently enrolled in a clinical trial involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study
- •Have participated in a clinical trial involving an investigational product within the 30 days before study entry
- •Have previously completed or withdrawn from this study or any other study investigating treprostinil or LY900014, and have previously received the investigational product
- •Have or used to have health problems or laboratory test results or ECG readings that, in the opinion of the doctor, could make it unsafe to participate, or could interfere with understanding the results of the study
研究者
相似试验
进行中（未招募）
1 期
A Study to Evaluate the Safety and Tolerability of JNJ-77730614 When Given as Single and Multiple Doses to Healthy Participants to Assess How Long JNJ 77730614 Stays in the Body (Pharmacokinetics) and How the Body Responds to it (Pharmacodynamics)Healthy VolunteersCTIS2023-505684-36-00Janssen - Cilag International92
尚未招募
不适用
Study to determine the safety and tolerability of combination therapy of TACE (Transarterial-chemoembolization) and Immunotherapy With the Autologous Killer Cell in patients with hepatocellular carcinoma: An open label studyKCT0007346Bundang CHA General Hospital10
已完成
不适用
Safety and tolerability of a vaginal ointment without any active drugs in healthy women.ACTRN12617000778381Zenith Technology Corporation Limited9
进行中（未招募）
不适用
A study investigating the safety, tolerability and pharmacodynamics of bacterial lipase in patients with cystic fibrosis and pancreatic insufficiencyRandomized, double-blind, placebo-controlled, single period, parallel group desigEUCTR2006-005180-25-DEordmark Arzneimittel GmbH20
已完成
不适用
A study to investigate the safety, tolerability and absorption and elimination of CCX507-B, a new drug for the treatment of patients with inflammatory bowel diseases, in healthy male and female subjects.Crohn's disease.Inflammatory bowel diseases10017969NL-OMON40895ChemoCentryx, Inc.30